Shots: Aristea to receive $60M as up front and $10M as equity investment in Aristea’s Series B financing. Arena gets an exclusive option to acquire Aristea, including rights to all […]readmore
Tags : Immune-Mediated Inflammatory Diseases
Shots: The companies collaborates on multiple projects, being the first for inflammatory bowel disease(IBD) to develop and discover therapies for treating Immune-Mediated Inflammatory Diseases (IMIDs) The focus of the collaboration […]readmore